TCTR20211004005尚未招募2 期
ChAdOx1 Vaccine Dose-Sparing Strategies in Post COVID-19 patients: A Randomized Controlled Trial
ational Research Council of Thailand (NRCT)0 个研究点目标入组 360 人开始时间: 2021年10月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Age 18 years or more
- •2. Recovered from COVID-19 for at least 3 months
- •3. Eligible for AstraZeneca Vaccination
- •4. Informed consent for participation
排除标准
- •History of allergy to a component of ChAdOx1/AZD1222 (AstraZeneca)
研究者
相似试验
已完成
4 期
Immunogenicity and safety of ChAdOx1 vaccine (Covid-19 vaccine) in Thai people with underlying diseaseDiabetes mellitusCirrhosissolid cancerHematologic malignancychronic kidney diseaserheumatological diseasecardiovascular diseaseChAdOx1 vaccineimmunogenicitycovid-19 vaccineTCTR20211228003Chulabhorn Royal Academy385
招募中
2 期
Immune response of booster dose with ChAdOx-1 in adult who had received 2 doses of CoronaVac (COVID-19)Prevention of COVID-19 with booster-dose strategy among healthy adult who received 2-dose of Coronavac using ChAdOx1 nCoV-19 vaccine.COVID-19 Vaccine, AstraZeneca Booster , Fractional low dose vaccineTCTR20210722003Health and Aging Platform, Chulalongkorn University400
招募中
不适用
Effects of Covieshield vaccine on Liver cirrhosis patientsCTRI/2021/03/032158Institute of Liver and Biliary Sciences
招募中
不适用
To determine the safety and antibody performance in Indian adults after taking COVID-19 vaccine.CTRI/2021/03/031998Advanced Cancer for Treatment Research and Education in cancer and Tata Memorial Centre
已完成
1 期
A study to test three experimental HIV vaccines in healthy adultsHIV/AIDSPACTR202006495409011niversity of Oxford88